VP - HEAD OF BIOLOGY
Dr. Lore Gruenbaum brings over 15 years of drug discovery and clinical development experience to Gotham, having worked on small molecule approaches and biologics in multiple therapeutic areas including chronic inflammation and autoimmune disease, cardiometabolic diseases, virology and oncology.
Most recently, Dr. Gruenbaum was part of the executive leadership team at Applied Biomath, where she led mechanistic modeling projects to inform drug development for a broad range of biotech and pharmaceutical companies. She also held a series of roles of increasing responsibility at both Roche and Boehringer Ingelheim. Dr. Gruenbaum obtained her Ph.D. in biochemistry from the Free University of Berlin and completed her postdoctoral training in neuroscience at Yale University.